Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Zithromac Iv Special Investigation For Legionella Infection.

Trial Profile

Zithromac Iv Special Investigation For Legionella Infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Community-acquired pneumonia; Legionnaires' disease; Pelvic inflammatory disorders
  • Focus Adverse reactions
  • Acronyms RESCUE-L
  • Sponsors Pfizer
  • Most Recent Events

    • 09 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 21 Nov 2016 Planned End Date changed from 1 Jan 2017 to 1 Dec 2016.
    • 09 Feb 2016 Planned End Date changed from 1 Feb 2016 to 1 Jan 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top